Intravenous anti-VEGF agents with RGD peptide-targeted core cross-linked star (CCS) polymers modified with indocyanine green for imaging and treatment of laser-induced choroidal neovascularization-Reference-Cited by-同舟云学术

Intravenous anti-VEGF agents with RGD peptide-targeted core cross-linked star (CCS) polymers modified with indocyanine green for imaging and treatment of laser-induced choroidal neovascularization

Published:2020 Issue:16 Volume:8 Page:4481-4491
ISSN:2047-4830
Container-title:Biomaterials Science
language:en
Short-container-title:Biomater. Sci.

Author:

Cai Wenting¹²³⁴⁵,Chen Qijing⁶⁷⁸⁹⁵^ORCID,Shen Tianyi¹²³⁴⁵,Yang Qian¹²³⁴⁵,Hu Weinan¹¹⁰¹¹¹²,Zhao Peng⁶⁷⁸⁹⁵^ORCID,Yu Jing¹²³⁴⁵^ORCID

Affiliation:

1. Department of Ophthalmology

2. Shanghai Tenth People's Hospital

3. Tongji University

4. School of Medicine

5. Shanghai

6. Institute for Translational Medicine

7. Institute for Biomedical Engineering and Nanoscience

8. Shanghai East Hospital

9. Tongji University School of Medicine

10. Anhui University of Science and Technology

11. Huainan

12. China

Abstract

S-PEG-ICG-RGD-RBZ NPs were synthesized to intravenously deliver anti-VEGF agents to choroidal neovascularization (CNV) areas for the treatment of CNV.

Funder

Natural Science Foundation of Shanghai

National Natural Science Foundation of China

Fundamental Research Funds for the Central Universities

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science,Biomedical Engineering

Link

http://pubs.rsc.org/en/content/articlepdf/2020/BM/C9BM02086A

Reference49 articles.

1. Can innate and autoimmune reactivity forecast early and advance stages of age-related macular degeneration?